Beckman Coulter has named Betty Woods non-executive chairman, the company said last week.

Woods, who is an 11-year veteran of the Beckman Coulter board, will succeed retiring executive chairman John Wareham. Woods is former president and CEO of Premera Blue Cross, and CEO of Premera, its holding company. She has been a member of the Beckman Coulter board since 1994. She is currently chair of the organization and compensation committee, Beckman said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.